Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Restorative Care

Restorative Care

Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Chronic Kidney Disease III: Interprofessional Care

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of Longitudinal Case-Based Learning on Students' Ability to Articulate the Pharmacists' Patient Care Process.

American journal of pharmaceutical education·2026

Same author

Development and evaluation of weighting methods for the 2024 national pharmacist workforce study.

Research in social & administrative pharmacy : RSAP·2026

Same author

Assessment of alpelisib-induced hyperglycemia in a real-world setting: A nationwide claims data analysis.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

Same author

Community pharmacists are not yet ready to manage oral anti-cancer agents: beyond safe dispensing and basic education.

The International journal of pharmacy practice·2026

Same author

The impact of data source on real-world medication adherence and exposure measures: From prescription to sold.

Journal of managed care & specialty pharmacy·2026

Same author

Community pharmacy practice transformation: Evaluating sustainability of patient care services.

Journal of the American Pharmacists Association : JAPhA·2026

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Community pharmacist-provided extended diabetes care.

William R Doucette¹, Matthew J Witry, Karen B Farris

¹Division of Clinical and Administrative Pharmacy, College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA. william-doucette@uiowa.edu

The Annals of Pharmacotherapy

|April 30, 2009

Summary

Community pharmacists effectively increased patient engagement in diabetes self-care activities. While clinical outcomes like A1C did not significantly change, this extended care model shows promise for lifestyle behavior modification in diabetes management.

Related Experiment Videos

Last Updated: Jun 23, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Area of Science:

Clinical Pharmacy
Diabetes Management
Patient Self-Care

Background:

Community pharmacists play a key role in diabetes treatment initiation and ongoing management.
Extended care services by community pharmacists beyond initial treatment are not well understood.
Patients with diabetes require continuous disease management support.

Purpose of the Study:

To assess the impact of community pharmacist-led extended diabetes care on clinical outcomes.
To evaluate changes in hemoglobin A1c (A1C), LDL cholesterol, and blood pressure.
To measure the effect on patients' self-reported diabetes self-care activities.

Main Methods:

A randomized controlled trial involving patients with diabetes who had prior education.
Specially trained pharmacists provided interventions during quarterly visits over 12 months.
Interventions included medication review, goal discussion, and self-care promotion; physician recommendations were made when needed.

Main Results:

Patients receiving pharmacist interventions significantly increased weekly engagement in diet and diabetes self-care activities.
No statistically significant differences were observed in 12-month changes of A1C, LDL-C, or blood pressure between groups.
The study included 66 participants (31 intervention, 35 control) in the final analysis.

Conclusions:

Pharmacist-provided extended care successfully enhanced patient participation in self-care behaviors.
Statistically significant improvements in primary clinical outcomes were not demonstrated within the study period.
Focusing on lifestyle and self-care behaviors is a valuable component of pharmacist-led diabetes care services.